共查询到19条相似文献,搜索用时 78 毫秒
1.
2.
3.
4.
目的 探索肺癌的基于临床路径的多学科协作诊疗模式。 方法 建立肺癌相关的临床路径知识库和多学科综合治疗讨论制度。 结果 共有8 532例肺癌患者通过多学科协作肺癌诊治模式进行诊治,综合讨论率达到95%以上。医疗业务相关指标均有所进步,2013年平均住院日由2012年的6天减少为5.4天,肺癌手术治疗、化疗、放疗患者的平均住院费用均下降,肺癌肺叶切除术后致命性血栓比率由0.93%减少到0.16%。结论 肺癌患者的多学科协作诊疗模式是提高诊疗水平、规范诊疗流程的重要途径,对于提高医疗质量、降低医疗费用、缩短住院日具有重要作用。 相似文献
5.
6.
7.
多学科一体化诊疗服务模式是新医改形势下中医医院坚持以病人为中心、顺应医学模式的转变、遵循中医思维模式而实施的医疗服务管理的改革。通过诊疗理念的革新和服务流程的再造,开展以病种为主线、以创建多专业服务平台为主要形式的一体化诊疗服务,突出中医药特色优势,强化了综合诊疗服务,推动中医医院服务能力的提升和整体医疗的发展。 相似文献
8.
随着医学学科不断细分,我国各家医院门诊逐渐从以往大内科、大外科的“一对多”诊疗模式转为专病、专科的“一对一”诊疗模式。但是“一对一”诊疗模式有其自身局限性,无法解决疑难杂症就诊不同专科的问题、患者来回奔波的困境。多专科协作诊疗的“多对一”诊疗模式是目前国际上积极倡导的新模式,其能给患者提供更加全面性、更加针对性的诊疗,但又因其人力成本高、不固定性强等特点,较难提高服务能力。对我国医院门诊的多专科协作诊疗模式进行现状分析,总结实践经验,为我国多专科协作诊疗模式的今后发展提供依据。 相似文献
9.
10.
11.
12.
13.
??????? 目的 基于前期研究,初步筛选部分有代表性的指标,客观评价和进行医疗中心设置的区域划分,可为政策制定提供参考。方法 根据文献研究,分别选取社会经济状况、地理环境、医疗资源和居民健康状况四个方面的指标,即人均GDP、人口密度、每千人口执业(助理)医师数和期望寿命指数进行聚类分析,对我国31个省、自治区、直辖市进行医疗中心的区域划分和客观评价。结果 上海、北京、天津单独成类,分别为第一类、第二类和第三类;山东、广东、辽宁、福建、江苏、浙江和内蒙古为第四类;河北、海南、吉林、黑龙江和山西为第五类;陕西、宁夏、安徽、河南、广西、四川、湖北、湖南和重庆为第六类;青海、新疆、云南、西藏、贵州、江西和甘肃为第七类。对于划分的不同区域,在进行国家医疗中心设置规划时,考虑采取不同的策略。结论 增进政府宏观调控和区域卫生规划,加强领导,争取多方配合,鼓励社会参与区域医疗中心的建设等。 相似文献
14.
Medical mistakes is an issue that challenges many healthcare providers and organizations. The challenges are professional, personal, systemswide, financial, and morally compelling; and a fully fitting response may depend on the answer to questions that H. Richard Niebuhr used to divide all ethical considerations: what is going on here; and what is the fitting response. Heartland Regional Medical Center in St. Joseph, Missouri, asked these questions about medication errors. The response model they developed, although it is very much a work in progress, shows how a facility can go from an ethical analysis to fixing the problem. 相似文献
15.
北京市区域医疗联合体系建设问题探究 总被引:1,自引:0,他引:1
为解决城乡和区域间医疗资源配置不均衡、不合理,基层医疗机构服务能力薄弱等问题,北京市2013年开展了区域医疗联合体系建设工作,虽然取得了一定的成绩,但从实践情况看来,政策实施的效果与预期还存在一定差距。以北京市区域医疗联合体系为研究对象,通过理论、实例相结合的方式,分析其在运行过程中出现的问题及造成这些问题的原因,为北京市区域医疗联合体系更好地发挥作用提供政策建议。 相似文献
16.
17.
18.
19.
Colin C Demasi MA Degaki TL Bustos-Valenzuela JC Figueira RC Montor WR Cruz LO Lojudice FH Muras AG Pereira TM Winnischofer SM Hasegawa AP Carreira AC Verbisck NV Corrêa RG Garay-Malpartida HM Mares-Guia TR Corrêa-Giannella ML Granjeiro JM Sogayar MC 《Molecular biotechnology》2008,39(2):89-95
Social and economical development is closely associated with technological innovation and a well-developed biotechnological industry. In the last few years, Brazil’s scientific production has been steadily increasing; however, the number of patents is lagging behind, with technological and translational research requiring governmental incentive and reinforcement. The Cell and Molecular Therapy Center (NUCEL) was created to develop activities in the translational research field, addressing concrete problems found in biomedical and veterinary areas and actively searching for solutions by employing a genetic engineering approach to generate cell lines over-expressing recombinant proteins to be transferred to local biotech companies, aiming at furthering the development of a national competence for local production of biopharmaceuticals of widespread use and of life-saving importance. To this end, mammalian cell engineering technologies were used to generate cell lines over-expressing several different recombinant proteins of biomedical and biotechnological interest, namely, recombinant human Amylin/IAPP for diabetes treatment, human FVIII and FIX clotting factors for hemophilia, human and bovine FSH for fertility and reproduction, and human bone repair proteins (BMPs). Expression of some of these proteins is also being sought with the baculovirus/insect cell system (BEVS) which, in many cases, is able to deliver high-yield production of recombinant proteins with biological activity comparable to that of mammalian systems, but in a much more cost-effective manner. Transfer of some of these recombinant products to local Biotech companies has been pursued by taking advantage of the São Paulo State Foundation (FAPESP) and Federal Government (FINEP, CNPq) incentives for joint Research Development and Innovation partnership projects. 相似文献